Location: Home
  • search
  • go
  • Relate News
  • 12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN
  • 12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China
  • 12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...
  • 12/30/2025Adlai Nortye Grants ASK Pharma Exclusive Rights for Pan-RAS Inhibitor ...
  • 12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801
  • 12/30/2025Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry
  • 12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China
  • 12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China
  • 12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...
  • 12/30/2025Suzhou Launches China's First Nuclear Medicine Demonstration Base
  • 12/30/2025China's Beautiful Biotech Chaos vs West's Elegant Paralysis (Asia Time...
  • 12/27/2025China Biotech Raises $362 Million in 18 Financing Deals in November 20...
  • 12/27/2025China Leads Globally in mRNA-Based Therapeutic Vaccine Development for...
  • 12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...
  • 12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
  • 12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
  • 12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
  • 12/27/2025Guangzhou Novaken Pharm Files for HKSE Main Board Listing
  • 12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval
  • 12/27/2025Frontera's HKSE IPO Application Accepted
  • 12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia
  • 12/27/2025LyncBio Therapeutics Completes Strategic Pre-A Financing Round
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025Chengdu Maxvax Biotech Completes D+ Financing Round
  • 12/27/2025Hemacell Completes Series B1 Financing to Advance Platelet Regeneratio...
  • 12/27/2025NMPA Announces Adoption of ICH E6(R3) Guidelines for Clinical Trial Qu...
  • 12/27/2025CDE Seeks Comments on Chinese Translation of ICH M8 eCTD Guidelines
  • 12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data
  • 12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
  • 12/23/2025PepBio Raises Series A Financing to Advance AI-Driven Peptide Drug Pip...
  • Page:7/814 Total number of articles:24393: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group